| ||||||||||||||||||||||||||||||||
Proffered Abstract (Oral Presentation): Colorectal Cancer Prevention |
and ß are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice.
Brigham & Women's Hospital, Boston, MA
Abstract
PR-01
Estrogen replacement therapy in post-menopausal women is associated with a reduction in colorectal cancer (CRC) risk, potentially via interactions between 17ß-estradiol (E2) and the estrogen receptors
and ß (ER
/ERß). To study the role of E2 in intestinal tumor inhibition, we separately crossed C57BL6-J/Min/+ (Min/+) mice with Er
+/- and Erß+/- mice to generate Er-deficient Min/+ progeny. We found an increased incidence of visible colon tumors and dysplastic microadenomas in Er-deficient Min/+ relative to Er+/+Min/+ controls. Small intestinal tumor numbers were unaffected. Invasive carcinomas were found only in Er
+/-Min/+ mice, suggesting that Er
plays additional non-cell autonomous roles that limit tumor progression. Histological analyses of Er-deficient Min/+ colons, as well as colons from ovariectomized Min/+ (OvxMin/+) and E2-treated OvxMin/+ (OvxMin/+ +E2) revealed significant differences in crypt architecture, enterocyte proliferation, and goblet cell differentiation relative to Min/+ and Er+/+Apc+/+ (WT) controls. The expression of Er
and Erß was regionally compartmentalized along the colonic crypt axis, suggesting functional antagonism. Our results indicate that Er
and Erß are inhibitory modifiers of Apc-dependent colon tumorigenesis. As a result, loss of E2 and ER signaling in post-menopausal women may contribute to CRC development.
| HOME | HELP | FEEDBACK | HOW TO CITE ABSTRACTS | ARCHIVE | CME INFORMATION | SEARCH |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |